Eccentric Cycling: A Promising Modality for Patients with Chronic Heart Failure.

Med Sci Sports Exerc

1School of Sport Science, Exercise and Health, The University of Western Australia, Crawley, AUSTRALIA; 2Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UNITED KINGDOM; 3Principal Research Fellow, National Health and Medical Research Council, AUSTRALIA; 4School of Physiotherapy and Exercise Science, Curtin University, Perth, AUSTRALIA; 5Allied Health Department, Fiona Stanley Hospital, Perth, AUSTRALIA; 6Centre for Exercise and Sports Science Research, School of Medical and Health Sciences, Edith Cowan University, Joondalup, AUSTRALIA; and 7Advanced Heart Failure and Cardiac Transplantation Unit, Fiona Stanley Hospital, Perth, AUSTRALIA.

Published: April 2017

Purpose: Chronic heart failure (CHF) is characterized by dyspnea and poor exercise tolerance, which decreases aerobic capacity (V˙O2peak), a measure strongly correlated with quality of life and mortality. In healthy populations, eccentric (ECC) cycling can be performed at a lower oxygen demand for matched workload, compared with concentric (CON) cycling, but few studies have previously investigated ECC cycling in CHF. We hypothesized that, when matched for external workload (W), an ECC cycling bout would be performed at a lower cardiorespiratory load (V˙O2) than CON in patients with CHF.

Methods: Eleven CHF patients (10 males) with impaired left ventricular systolic function (ejection fraction 31% ± 12%) completed a CON V˙O2peak test, with the subsequent ECC and CON protocols set at 70% of individual maximal CON power (W). Oxygen consumption (V˙O2), RER, minute ventilation (V˙E), HR, and rate pressure product were compared between conditions.

Results: ECC was performed at a lower V˙O2 (12.3 ± 1.3 vs 14.1 ± 0.8 mL·kg·min, P = 0.01), RER (0.92 ± 0.02 vs 0.96 ± 0.01, P = 0.01), and V˙E (36.5 ± 4.4 vs 40.2 ± 2.0 L·min, P = 0.04) in comparison with CON, despite both conditions being performed at matched workloads. HR (101 ± 5 vs 96 ± 1 bpm, P = 0.06) and rate pressure product (13,539 ± 788 vs 11,911 ± 227 bpm·mm Hg, P = 0.15) were not significantly different between conditions.

Conclusion: When matched for external workload, ECC cycling can be performed with a lower oxygen demand than CON in patients with CHF. Eccentric cycling is a promising modality for cardiac rehabilitation in severely deconditioned patients with CHF.

Download full-text PDF

Source
http://dx.doi.org/10.1249/MSS.0000000000001151DOI Listing

Publication Analysis

Top Keywords

ecc cycling
16
performed lower
16
eccentric cycling
8
cycling promising
8
promising modality
8
chronic heart
8
heart failure
8
cycling performed
8
lower oxygen
8
oxygen demand
8

Similar Publications

Background: Emergency medical services attend out-of-hospital cardiac arrests all across Australia. Resuscitation by emergency medical services is attempted in nearly half of all cases. However, resuscitation skills can degrade over time without adequate exposure, which negatively impacts patient survival.

View Article and Find Full Text PDF

Purpose: SWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly diagnosed advanced biliary tract cancers (BTCs).

Methods: Patients with newly diagnosed locally advanced unresectable or metastatic BTC, including intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) and gallbladder carcinoma (GBC), were randomly assigned 2:1 to either GAP (gemcitabine 800 mg/m, cisplatin 25 mg/m, and nab-paclitaxel 100 mg/m intravenously once per day on days 1 and 8 of a 21-day cycle) or GC (gemcitabine 1,000 mg/m and cisplatin 25 mg/m intravenously once per day on days 1 and 8 of a 21-day cycle).

Results: Among 452 randomly assigned participants, 441 were eligible and analyzable, 67% with ICC, 16% with GBC, and 17% with ECC.

View Article and Find Full Text PDF

Background: Joint stiffness endurance is considered essential in many sports events. We previously reported that reduced joint stiffness due to repetitive hopping was associated with reduced active muscle stiffness. However, the determinants of active muscle stiffness endurance were unknown.

View Article and Find Full Text PDF

Ultrasound (US) based radiomics is susceptible to variations in scanners, sonographers. To retrospectively investigate the feasibility of an adapted cycle generative adversarial networks (CycleGAN) in the style transfer to improve US based radiomics in the prediction of lymph node metastasis (LNM) with images from multiple scanners for patients with early cervical cancer (ECC). The CycleGAN was firstly trained to transfer paired US phantom images from one US device to another one; the model was then further trained and tested with clinical US images of ECC by transferring images from four US devices to one specific device; finally, the adapted model was tested with its effects on the radiomics feature harmonization and accuracy of LNM prediction in US based radiomics for ECC patients.

View Article and Find Full Text PDF
Article Synopsis
  • Photodynamic therapy (PDT) can induce necrosis and apoptosis in extrahepatic cholangiocarcinoma (ECC) cells, but its effectiveness is limited due to shallow tissue penetration and weak therapeutic impact, making complete tumor eradication challenging.
  • This study investigates how ferroptosis, a type of cell death, interacts with Hematoporphyrin-mediated PDT, analyzing the effects of various ferroptosis inducers on the treatment's effectiveness.
  • Results show that combining PDT with ferroptosis inducers like Lenvatinib or Erastin increases reactive oxygen species levels, decreases antioxidant levels, and enhances cell death in cholangiocarcinoma cells, suggesting a promising strategy to improve PDT outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!